Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 14;13(1):19.
doi: 10.1186/s13741-024-00376-w.

Analysis of inappropriate prophylactic use of proton pump inhibitors during the perioperative period: an observational study

Pengpeng Liu  1 , Guangyao Li  1 , Qian Wu  2 , Mei Han  3 , Chao Zhang  4
Affiliations

Analysis of inappropriate prophylactic use of proton pump inhibitors during the perioperative period: an observational study

Pengpeng Liu et al. Perioper Med (Lond). .

Abstract

Background: The prevalence and characteristics of inappropriate use of proton pump inhibitors (PPIs) to prevent stress-related mucosal disease (SRMD) during the perioperative period and its associated factors are rarely reported. This study aimed to investigate the prevalence and characteristics of inappropriate prophylactic use of proton pump inhibitors (PPIs) during the perioperative period and identify its associated factors in a tertiary care and academic teaching hospital in China and to provide evidence for regulation authorities and pharmacists to take targeted measures to promote rational drug use.

Methods: Inpatients who underwent surgical operations and received prophylactic use of PPIs from June 2022 to November 2022 were included in this retrospective study. The appropriateness of perioperative prophylactic use of PPIs was evaluated by clinical pharmacists. Associated factors with inappropriate perioperative prophylactic use of PPIs were analyzed by univariable and multivariable logistic regression.

Results: Four-hundred seventy-two patients were finally included in this study, of which 131 (27.75%) patients had at least one problem with inappropriate perioperative prophylactic use of PPIs. The three most common problems were drug use without indication (52.0%), inappropriate usage and dosage (34.6%), and inappropriate duration of medication (6.7%). Multiple logistic regression analysis showed that oral dosage form of PPIs [OR = 18.301, 95% CI (7.497, 44.671), p < 0.001], discharge medication of PPIs [OR = 11.739, 95% CI (1.289, 106.886), p = 0.029], and junior doctors [OR = 9.167, 95% CI (3.459, 24.299), p < 0.001] were associated with more inappropriate prophylactic use of PPIs. Antithrombotics [OR = 0.313, 95% CI (0.136, 0.721), p = 0.006] and prolonged postoperative hospital stay (longer than 15 days) [OR = 0.262, 95% CI (0.072, 0.951), p = 0.042] were associated with less inappropriate prophylactic use of PPIs.

Conclusions: The inappropriate prophylactic use of PPIs during the perioperative period is common. Regulation authorities and pharmacists should take more targeted measures to promote the rational prophylactic use of PPIs during the perioperative period.

Keywords: Perioperative period; Prophylaxis; Proton pump inhibitors; Stress-related mucosal disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flowchart of the patient selection process
Fig. 2
Fig. 2
Characterization and percentages of the 179 cases of inappropriate prophylactic use of PPIs during the perioperative period
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Alhazzani W, Alshamsi F, Belley-Cote E, Heels-Ansdell D, Brignardello-Petersen R, Alquraini M, et al. Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med. 2018;44(1):1–11. doi: 10.1007/s00134-017-5005-8. - DOI - PMC - PubMed
    1. Ali O, Poole R, Okon M, Maunick S, Troy E. Irrational use of proton pump inhibitors in general practice. Ir J Med Sci. 2019;188(2):541–544. doi: 10.1007/s11845-018-1891-1. - DOI - PubMed
    1. American Society of Health-System Pharmacists ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm. 1999;56:347–379. doi: 10.1093/ajhp/56.4.347. - DOI - PubMed
    1. Bai Y, Li Y, Ren X, Li Z. Expert advice on the prevention and treatment of stress ulcer (2018) Natl Med J China. 2018;98(42):3392–3394.
    1. Bardou M, Quenot JP, Barkun A. Stress-related mucosal disease in the critically ill patient. Nat Rev Gastroenterol Hepatol. 2015;12(2):98–107. doi: 10.1038/nrgastro.2014.235. - DOI - PubMed

LinkOut - more resources